Cipla Limited has informed the Exchange regarding a press release dated October 12, 2020, titled "Avenue Therapeutics, Inc. receives complete response letter from the FDA for IV Tramadol".
Press Release Oct 12 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Cipla
Later from Cipla
- Press Release Oct 20 2020
- Press Release Oct 28 2020
- Press Release Nov 06 2020
- Press Release Nov 18 2020
- Press Release Dec 11 2020
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla